Tata groups

The Tata CRISPR COVID-19 test, Feluda, has received authorization from the Drugs Controller General of India. Reportedly, Feluda's COVID-19 detection accuracy is at par with the RT-PCR test. Moreover, Feluda is cost-effective, easier to use, and time saving. The company said, the technology can be further configured to detect other pathogens as well besides ramping up the tests. Feluda test is developed by CSIR-IGIB in association with Tata… read-more